Assessment of urinary bone markers for monitoring treatment of osteoporosis

Clinical Chemistry

Volumn 50, Issue 12, 2004, Pages 2263-2270

  Worsfold, Michael ^a   Powell, Diane E ^a   Jones, Teresa J W ^a   Davie, Michael W J ^a  

^a ROBERT JONES AND AGNES HUNT ORTHOPAEDIC HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; BISPHOSPHONIC ACID DERIVATIVE; DEOXYPYRIDINOLINE; ESTROGEN;

ADULT; AGED; ARTICLE; BONE DENSITY; CALCIUM INTAKE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTROGEN THERAPY; FEMALE; HIP; HUMAN; INTERMETHOD COMPARISON; LUMBAR SPINE; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PATIENT MONITORING; URINALYSIS;

AGED; AGED, 80 AND OVER; AMINO ACIDS; BIOLOGICAL MARKERS; BONE DENSITY; CALCIUM; COLLAGEN; COLLAGEN TYPE I; DIETARY SUPPLEMENTS; DIPHOSPHONATES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; MONITORING, PHYSIOLOGIC; OSTEOPOROSIS, POSTMENOPAUSAL; PEPTIDES; REFERENCE VALUES; SPINE;

EID: 9244234388     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.037424     Document Type: Article

References (19)

1. Riggs BL, Melton LJ III. Bone turnover matters: the Raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density. J Bone Miner Res 2002;17:11-4.
2. Lenchik L, Kiebzak GM, Blunt BA. What is the role of serial bone mineral density measurements in patient management? J Clin Densitom 2002;5:S29-38.
3. Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 1994;79:1693-700.
4. Garnero P, Gineyts E, Arbault P, Christiansen C, Delmas P. Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion. J Bone Miner Res 1995;10:641-9.
5. Woitge HW, Knothe A, Witte K, Schmidt-Gayk H, Ziegler R, Lemmer B, et al. Circannual rhythms and interactions of vitamin D metabolites, parathyroid hormone, and biochemical markers of skeletal homeostasis: a prospective study. J Bone Miner Res 2000;15:2443-50.
6. Hannon R, Blumsohn A, Naylor K, Eastell R. Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability. J Bone Miner Res 1998;13:1124-33.
7. Garnero P, Delmas PD. Variability and response of urinary resorption markers to hormone replacement therapy. J Bone Miner Res 1999;14:470-1.
8. Ravn P, Bidstrup M, Wasnich RD, Davis JW, McClung MR. Balske A, et al. Alendronate and estrogen-progestin on the long-term prevention of bone loss: four-year results from the early postmenopausal intervention cohort study. Ann Intern Med 1999;131:935-42.
9. Ravn P, Weiss SR, Rodriguez-Portales JA, McClung MR, Wasnich RD, Gilchrist NL, et al. Alendronate in early postmenopausal women: effects on bone mass during long-term treatment and after withdrawal. J Clin Endocrinol Metab 2000;85:1492-7.
10. 3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int 2002;13:257-64.
11. Fink E, Cormier C, Steinmetz P, Kindermans C, Le Bouc Y, Souberbielle JC. Differences in the capacity of several biochemical bone markers to assess high bone turnover in early menopause and response to alendronate therapy. Osteoporos Int 2000;11:295-303.
12. Jones T, Davie MWJ. Bone mineral density at the distal forearm can identify patients with osteoporosis at spine or femoral neck. Br J Rheumatol 1998;37:539-43.
13. Davie MWJ. Fractures at specific sites indicate low bone mineral density at lumbar spine and femoral neck in women. J Orthop Rheumatol 1996;9:41-5.
14. Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137-41.
15. Fuller NJ, Elia M. Factors influencing the production of creatinine: implications for the determination and interpretation of urinary creatinine and creatine in man. Clin Chim Acta 1988;175:199-210.
16. Fraser CG, Harris EK. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989;27:409-37.
17. Eastell R, Mallinak N, Weiss S, Ettinger M, Pettinger M, Cain D, et al. Biological variability of serum and urinary N-telopeptides of type I collagen in postmenopausal women. J Bone Miner Res 2000;15:594-8.
18. Harris EK, Brown S. Temporal changes in the concentrations of serum constituents in healthy men. Ann Clin Biochem 1979;16:169-76.
19. Mazzuoli G, Marinucci D, D'Erasmo E, Acca M, Pisani D, Rialdi MG, et al. Cyclical behavior of bone remodeling and bone loss in healthy women after menopause: results of a prospective study. Bone 2002;31:718-24.